Skip to Main Content
Contribute Try STAT+ Today

Good morning, everyone, and how are you today? A spot of rain, and then some, is dousing the Pharmalot campus, but we are looking past the clouds and pandemic gloom. After all, the glass is always half full, yes? As George Burns used to say, “I look to the future, because that’s where I’m going to spend the rest of my life.” So join us as we hoist a cup of stimulation to celebrate what lies ahead. And dig in to the list of interesting items below, too. Hope you have a splendid day and stay dry …

The moment some parents have been anxiously awaiting for months is almost here: The Covid-19 vaccine made by Pfizer (PFE) and BioNTech (BNTX) for children aged 5 to 11 will likely be authorized for use in the next week, after completing a four-step process that begins today, STAT explains. It is also a moment some parents have been dreading for months. And over the weekend, they made their concerns known to experts on the Food and Drug Administration’s vaccines advisory committee, which meets today to review the evidence on the safety and efficacy of the vaccine for this age group, with an organized email campaign urging the panel not to recommend the shot.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment